HJ Science Co., Ltd. will convene its Board of Directors on 28 August 2026 to review and approve the interim financial results for the six months ended 30 June 2026, according to an announcement released on 18 August 2026.
The meeting agenda includes consideration of the consolidated interim statements and subsequent public disclosure of the results. The Board currently comprises four executive directors (including Chairman and CEO Dr. Ji Jianxin), four non-executive directors, and four independent non-executive directors.